Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novartis describes discovery and clinical results with ERK1/2 inhibitor LTT-462

Sep. 14, 2020

FCN-437c enters phase II trial in China for advanced breast cancer

Sep. 14, 2020

Bicycle opens phase I/II study of BT-8009 in advanced solid tumors

Sep. 14, 2020

New phase II trial examines suprachoroidal administration of AU-011 in primary choroidal melanoma

Sep. 14, 2020

Constellation Pharmaceuticals discovers new CBP and KAT3B inhibitors

Sep. 14, 2020

Discovery of novel orally active and selective PI3Kalpha inhibitor

Sep. 14, 2020

Aerie Pharmaceuticals presents new Rho and JAK inhibitors

Sep. 14, 2020

Voronoi patents new RET inhibitors

Sep. 14, 2020

FDA clears IND for phase I study of APR-003

Sep. 14, 2020

Beijing Konruns begins phase I study of KC-1036 in advanced solid tumors

Sep. 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...